SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 87)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
30-Sep-2016

8895516: Modified saccharides, conjugates thereof, and their manufacture

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/202

30-Sep-2016

(X0) 10564474: Ultrafiltration for preparing outer membrane vesicles

(A1) 20070087017: Ultrafiltration for preparing outer membrane vesicles

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/235

30-Sep-2016

8568734: Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8206720: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND INVASIN POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZIATION EPITOPES.

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/283

30-Sep-2016

(X0) 10576732: STABILISED COMPOSITIONS

(A1) 20070110809: STABILISED COMPOSITIONS

(B2) 7883709: STABILISED COMPOSITIONS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/347

30-Sep-2016

(X0) 11662371: Glycosylceramide Adjuvant for Saccharide Antigens

(A1) 20080199487: Glycosylceramide Adjuvant for Saccharide Antigens

(B2) 8790654: Glycosylceramide Adjuvant for Saccharide Antigens

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/376

30-Sep-2016

9151756: CHLAMYDIA ANTIGENS

8568732: CHLAMYDIA ANTIGENS

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/439

30-Sep-2016

(X0) 14432848: NONLINEAR SACCHARIDE CONJUGATES

(A1) 20160101187: NONLINEAR SACCHARIDE CONJUGATES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/479

30-Sep-2016

(X0) 14764997: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

(A1) 20150366796: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/565

30-Sep-2016

(X0) 14652234: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

(A1) 20150320852: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/620

30-Sep-2016

(X0) 14775760: RNA PURIFICATION METHODS

(A1) 20160024139: RNA PURIFICATION METHODS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/668

30-Sep-2016

(X0) 14786641: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

(A1) 20160067326: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/712

30-Sep-2016

(X0) 14435258: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

(A1) 20150273036: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39894/145

08-Aug-2016

9156894: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8398999: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8226960: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

NOVARTIS AG

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39348/942

05-Aug-2016

(X0) 14989737: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

(A1) 20160199476: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39336/946

03-Aug-2016

8637044: Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8168194: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) TAT SCAFFOLD POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZATION EPITOPES.

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39315/838

01-Aug-2016

(X0) 14918417: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

(A1) 20160039887: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39292/434

20-Jun-2016

(X0) 14961772: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

(A1) 20160158335: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38945/527

15-Jun-2016

8158418: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7572453: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7531180: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

9255126: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/296

15-Jun-2016

8753651: Capsular polysaccharide solubilisation and combination vaccines

9358278: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

8889152: Capsular Polysaccharides Solubilisation and Combination Vaccines

8852606: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

NOVARTIS AG

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/319

15-Jun-2016

(X0) 10858858: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(A1) 20050118275: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(B2) 9107831: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/339

15-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/378

15-Jun-2016

(X0) 13982042: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

(A1) 20140017279: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/385

15-Jun-2016

(X0) 14381513: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(A1) 20150125475: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(B2) 9320748: IMMUNOLOGICALLY USEFUL ARGININE SALTS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/441

15-Jun-2016

(X0) 14424370: IMMUNOGENIC COMPOSITION

(A1) 20150224204: IMMUNOGENIC COMPOSITION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/464

10-Jun-2016

(X0) 12816534: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(A1) 20110312510: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(B2) 9365885: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38865/714

08-Jun-2016

(X0) 10543455: Injectable vaccines against multiple meningococcal serogroups

(A1) 20070082014: Injectable vaccines against multiple meningococcal serogroups

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/172

08-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/509

08-Jun-2016

(X0) 14357270: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

(A1) 20140314703: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/764

08-Jun-2016

(X0) 13790948: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(A1) 20130236492: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(B2) 9375471: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38829/915

02-Jun-2016

(X0) 15015041: COMBINATION NEISSERIAL COMPOSITIONS

(A1) 20160151476: COMBINATION NEISSERIAL COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38595/473

01-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38754/706

14-Mar-2016

(X0) 14363387: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

(A1) 20150132333: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/417

14-Mar-2016

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/441

04-Mar-2016

(X0) 14363387: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

(A1) 20150132333: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37880/900

24-Feb-2016

(X0) 13997017: PROCESSES FOR PURIFYING C. DIFFICILE PS-II SACCHARIDE WITH ACID AND EMZYME TREATMENTS

(A1) 20130315959: PROCESSES FOR PURIFYING C. DIFFICILE PS-II SACCHARIDE WITH ACID AND EMZYME TREATMENTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37792/850

24-Feb-2016

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37792/925

24-Feb-2016

(X0) 11666786: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

(A1) 20100015212: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

(B2) 9206399: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

37800/287